Steven Doerr, MD, is a U.S. board-certified Emergency Medicine Physician. Dr. Doerr received his undergraduate degree in Spanish from the University of Colorado at Boulder. He graduated with his Medical Degree from the University Of Colorado Health Sciences Center in Denver, Colorado in 1998 and completed his residency training in Emergency Medicine from Denver Health Medical Center in Denver, Colorado in 2002, where he also served as Chief Resident.
Dr. Charles "Pat" Davis, MD, PhD, is a board certified Emergency Medicine doctor who currently practices as a consultant and staff member for hospitals. He has a PhD in Microbiology (UT at Austin), and the MD (Univ. Texas Medical Branch, Galveston). He is a Clinical Professor (retired) in the Division of Emergency Medicine, UT Health Science Center at San Antonio, and has been the Chief of Emergency Medicine at UT Medical Branch and at UTHSCSA with over 250 publications.
Leprosy is a curable disease with the initiation and completion of MDT.
Treatment with MDT can prevent the disfigurement and neurologic disability
associated with leprosy.
Prognosis depends on the stage of the disease at the time of diagnosis, as
well as on the initiation and compliance with MDT.
Skin discoloration and skin damage generally persist even after treatment
Progression of neurologic impairment can be limited with MDT. In general,
however, there is partial or no recovery from neurologic damage already suffered
(muscle weakness and loss of sensation).
Relapse of leprosy after treatment with MDT is rare.
Leprosy is only rarely fatal.
Patients must be educated to be aware of the signs and symptoms of relapse
and disease exacerbations (type 1 and type 2 reactions).
Injury prevention is important to avoid chronic disability.
Public awareness and education campaigns are necessary for the early
identification and treatment of leprosy, in addition to eliminating the social
stigma and isolation associated with the disease.
The WHO public-health initiative has been extremely successful in working
toward the elimination of leprosy worldwide. Political and economic support
need to continue in order to sustain elimination and progress toward further
reducing the prevalence of leprosy globally.